SVOBODA, Pavel, Jan HAVIERNIK, Petr BEDNÁŘ, Milos MATKOVIC, Tomas Cervantes RINCO, Jennifer KEEFFE, Martin PALUS, Jiri SALAT, Marianna AGUDELO, Michel C NUSSENZWEIG, Andrea CAVALLI, Davide F ROBBIANI and Daniel RŮŽEK. A combination of two resistance mechanisms is critical for tick-borne encephalitis virus escape from a broadly neutralizing human antibody. Cell Reports. Elsevier Inc., 2023, vol. 42, No 9, p. 1-16. ISSN 2211-1247. Available from: https://dx.doi.org/10.1016/j.celrep.2023.113149.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A combination of two resistance mechanisms is critical for tick-borne encephalitis virus escape from a broadly neutralizing human antibody
Authors SVOBODA, Pavel (203 Czech Republic, belonging to the institution), Jan HAVIERNIK (203 Czech Republic, belonging to the institution), Petr BEDNÁŘ (203 Czech Republic, belonging to the institution), Milos MATKOVIC, Tomas Cervantes RINCO, Jennifer KEEFFE, Martin PALUS, Jiri SALAT, Marianna AGUDELO, Michel C NUSSENZWEIG, Andrea CAVALLI, Davide F ROBBIANI and Daniel RŮŽEK (203 Czech Republic, guarantor, belonging to the institution).
Edition Cell Reports, Elsevier Inc. 2023, 2211-1247.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 8.800 in 2022
RIV identification code RIV/00216224:14310/23:00132673
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1016/j.celrep.2023.113149
UT WoS 001101035500001
Keywords in English tick-borne encephalitis; tick-borne encephalitis virus; monoclonal antibody; escape mutant; neutralization
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 5/4/2024 15:44.
Abstract
Tick-borne encephalitis virus (TBEV) is a flavivirus that causes human neuroinfections and represents a growing health problem. The human monoclonal antibody T025 targets envelope protein domain III (EDIII) of TBEV and related tick-borne flaviviruses, potently neutralizing TBEV in vitro and in preclinical models, representing a promising candidate for clinical development. We demonstrate that TBEV escape in the presence of T025 or T028 (another EDIII-targeting human monoclonal antibody) results in virus variants of reduced pathogenicity, characterized by distinct sets of amino acid changes in EDII and EDIII that are jointly needed to confer resistance. EDIII substitution K311N impairs formation of a salt bridge critical for T025-epitope interaction. EDII substitution E230K is not on the T025 epitope but likely induces quaternary rearrangements of the virus surface because of repulsion of positively charged residues on the adjacent EDI. A combination of T025 and T028 prevents virus escape and improves neutralization.
Links
LM2018127, research and development projectName: Česká infrastruktura pro integrativní strukturní biologii (Acronym: CIISB)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 29/6/2024 10:48